1027 Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of signal transducers and activators of transcription 3
β Scribed by K.F. Chen; T.H. Liu; W.T. Tai; P.J. Chen; A.L. Cheng
- Book ID
- 119600081
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 47 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The activation of signal transducers and activators of transcription 3 (STAT3) has been closely linked with the proliferation, survival, invasion, and angiogenesis of hepatocellular carcinoma (HCC) and represents an attractive target for therapy. In the present report, we investigated w
## Abstract This article shows that HepG2, Hep3B, and SKβHep1 cells, three lines of human hepatocellular carcinoma (HCC) cells, are resistant to apoptosis induced by tumor necrosis factorβrelated apoptosisβinducing ligand (TRAIL). Parthenolide, a sesquiterpene lactone found in European feverfew, ha